ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 96 filers reported holding ENDOCYTE INC in Q4 2016. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $4,684,000 | +138.0% | 263,762 | +85.0% | 0.00% | +100.0% |
| Q2 2018 | $1,968,000 | +475.4% | 142,599 | +7.2% | 0.00% | – |
| Q1 2017 | $342,000 | -2.6% | 133,055 | -3.3% | 0.00% | – |
| Q4 2016 | $351,000 | -19.1% | 137,558 | -2.1% | 0.00% | – |
| Q3 2016 | $434,000 | -3.8% | 140,568 | 0.0% | 0.00% | – |
| Q2 2016 | $451,000 | +6.1% | 140,568 | +2.6% | 0.00% | – |
| Q1 2016 | $425,000 | -22.7% | 137,061 | 0.0% | 0.00% | – |
| Q4 2015 | $550,000 | -34.7% | 137,061 | -25.4% | 0.00% | -100.0% |
| Q3 2015 | $842,000 | +3.8% | 183,814 | +17.6% | 0.00% | 0.0% |
| Q2 2015 | $811,000 | -8.0% | 156,273 | +10.9% | 0.00% | 0.0% |
| Q1 2015 | $882,000 | +4.6% | 140,861 | +5.1% | 0.00% | 0.0% |
| Q4 2014 | $843,000 | -6.3% | 133,998 | -9.5% | 0.00% | 0.0% |
| Q3 2014 | $900,000 | -7.6% | 148,000 | +0.1% | 0.00% | 0.0% |
| Q2 2014 | $974,000 | -65.2% | 147,875 | +26.0% | 0.00% | -50.0% |
| Q1 2014 | $2,795,000 | +114.3% | 117,403 | -3.7% | 0.00% | +100.0% |
| Q4 2013 | $1,304,000 | -43.9% | 121,961 | -30.0% | 0.00% | -50.0% |
| Q3 2013 | $2,323,000 | -6.5% | 174,258 | -7.9% | 0.00% | 0.0% |
| Q2 2013 | $2,484,000 | – | 189,196 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 4,300,000 | $59,340,000 | 17.76% |
| RA Capital Management | 5,649,884 | $77,968,000 | 5.06% |
| Avoro Capital Advisors LLC | 5,695,200 | $78,594,000 | 3.03% |
| Crosspoint Capital Strategies, LLC | 107,620 | $1,485,000 | 2.84% |
| Ghost Tree Capital, LLC | 500,000 | $6,900,000 | 2.03% |
| EMORY UNIVERSITY | 205,295 | $2,833,000 | 1.88% |
| Asymmetry Capital Management, L.P. | 103,159 | $1,424,000 | 1.40% |
| NEXTHERA CAPITAL LP | 596,000 | $8,225,000 | 1.27% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,324,299 | $32,075,000 | 1.13% |
| PFM Health Sciences, LP | 4,068,608 | $56,147,000 | 0.88% |